Novo weight loss drug trial shows improvement in fatty liver disease
Novo Nordisk said Friday that its weight-loss drug achieved the primary goal of a late-stage study in patients with fatty liver disease, reducing scarring of the organ without worsening the condition.
ПОПУЛЯРНЫЕ ПОСТЫ
Vigilante groups patrol flood zone in Paiporta
Ноябрь 7, 2024
At least 89 people are missing in flooding in eastern Spain
Ноябрь 7, 2024
Hurricane Rafael hit the Cayman Islands
Ноябрь 7, 2024
ПОДПИСЫВАЙТЕСЬ НА НАС
ПРЯМАЯ ТРАНСЛЯЦИЯ